Mai, Elaine

Antibody targeting of E3 ubiquitin ligases for receptor degradation

Marei, H., Tsai, W.-T. K., Kee, Y.-S., Ruiz, K., He, J., Cox, C., Sun, T., Penikalapati, S., Dwivedi, P., Choi, M., et al. (2022) · Nature

Protein Degradation and InhibitorsUbiquitin and proteasome pathways

Cited by 273

HER2-targeted therapy reduces incidence and progression of midlife mammary tumors in female murine mammary tumor virus huHER2-transgenic mice

Finkle, D., Quan, Z. R., Asghari, V., Kloss, J., Ghaboosi, N., Mai, E., Wong, W. L., Hollingshead, P., Schwall, R., Koeppen, H., et al. (2004) · Clinical Cancer Research

HER2/EGFR in Cancer ResearchBreast Cancer Treatment Studies

Cited by 125

Modeling the efficacy of trastuzumab-DM1, an antibody drug conjugate, in mice

Jumbe, N. L., Xin, Y., Leipold, D. D., Crocker, L., Dugger, D., Mai, E., Sliwkowski, M. X., Fielder, P. J., & Tibbitts, J. (2010) · Journal of Pharmacokinetics and Pharmacodynamics

HER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies Research

Cited by 119